Provider of drug development and discovery services. The company develops and researches on radiopharmaceuticals for diagnostic and therapeutic applications.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Biosynthema‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Jack Erion Ph.D | President and Chief Executive Officer |